Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.08
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
0.80
Today|||52-Week Range
3.86
-38.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-21.0M-15.7M-14.5M-15.0M
 
 
 
 
 
Depreciation262.0K389.0K965.0K959.0K
 
 
 
 
 
Total Other Cash Flow8.2M1.1M1.7M2.3M
 
 
 
 
 
Funds From Operations-13.7M-14.2M-11.9M-11.7M
 
 
 
 
 
Funds From/For Other Operating Expenses3.2M-1.4M2.6M-226.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-16.9M-12.7M-14.5M-11.4M
 
 
 
 
 
 
InvestingIncrease In Investments-9.8M-22.8M-22.5M-48.1M
 
 
 
 
 
Decrease In Investments31.2M31.0M27.4M14.0M
 
 
 
 
 
Capital Expenditures-270.0K-157.0K-2.2M-2.5M
 
 
 
 
 
Net Cash Flow Investing21.1M8.0M2.7M-36.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.001.2M-158.0K
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-30.0K-57.0K0.000.00
 
 
 
Net Proceeds Stock Sale116.0K190.0K162.0K2.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing101.0K154.0K504.0K700.0K
 
 
 
 
 
Net Cash Flow - Financing-15.0K-21.0K872.0K1.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash4.2M-4.7M-10.8M-46.3M